Delivery Order SPE2DB22D3401-SPE2DB25FT5NF
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp for Doxycycline Monohydrate 100 mg capsules (250-count units) valued at $1,571.53 with a firm fixed price structure. The order, issued on September 24, 2025, represents a non-competitive set-aside award and is scheduled for completion by September 25, 2025. AmerisourceBergen's corporate office in Conshohocken, Pennsylvania serves as the place of performance for this pharmaceutical supply delivery, which supports...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Doxycycline IR-DR 40 mg capsules (30-count) with a contract value of $3,077.22. This is a firm fixed-price delivery order with an ultimate completion date of August 27, 2025, and no set-aside designation was utilized. The order will be performed in Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters. This delivery order represents a child...
- The Defense Logistics Agency awarded a delivery order valued at $1,000.28 to AmerisourceBergen Drug Corp for Doxycycline Hyclate 50 mg capsules (500-count supply) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, non-set-aside contract employs firm fixed-price pricing and will be performed at the company's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,413.11 to AmerisourceBergen Drug Corp for the supply of Doxycycline Mono 100 mg tablets (250-count unit) on May 30, 2025, with an ultimate completion date of June 2, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a continuation of the company's role as...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 7, 2025, for the supply of Doxycycline Hyclate 100 mg capsules (500-count) with a ceiling value of $1,538.36. This firm fixed-price contract, which utilizes no set-aside designation, is scheduled for completion by August 8, 2025, with performance at the vendor's Conshohocken, Pennsylvania facility. The delivery order represents a continuation of AmerisourceBergen's extensive pharmaceutical supply...
- The Defense Logistics Agency awarded a delivery order valued at $4,884.22 to AmerisourceBergen Drug Corp for the supply of Doxycycline Hyclate 100 mg capsules (500-count units). This competitively awarded, firm fixed-price delivery order was issued on August 22, 2025, with an ultimate completion date of August 25, 2025. The contract carries no set-aside designation, and the place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate...
- The Defense Logistics Agency awarded a delivery order valued at $6,895.70 to AmerisourceBergen Drug Corp for the supply of Doxycycline Monohydrate 100 mg capsules (250-count) on August 22, 2025, with an ultimate completion date of August 25, 2025. This is a firm fixed price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This contract represents a...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 27, 2025, for the supply of Doxycycline 50 mg tablets in quantities of 60 units, with a ceiling value of $47,967.46. This firm fixed-price delivery order represents a non-set-aside competitive award and is scheduled for completion by August 28, 2025. The contract is being performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on June 18, 2025, for the supply of Doxycycline Hyclate 100 mg tablets in quantities of 1,000 units, with a contract ceiling value of $1,402.20. This is a firm fixed-price delivery order with no set-aside designation, reflecting competitive procurement through open competition. The order is scheduled for ultimate completion by June 20, 2025, and will be performed at AmerisourceBergen's corporate office...
- This contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, was issued by the Defense Logistics Agency (DLA) for the delivery of 4,568,173,863 units of doxycycline monohydrate 100 mg capsules. The $4,487.10 firm fixed-price delivery order has a performance period through May 8, 2025 and is not designated as a set-aside. Amerisourcebergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical to provide a wide range of...
- SPE2DB22D3401Indefinite Delivery Contract
- SPE2DB22D3401-SPE2DB25FT5NFDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 6, 2025, for the supply of Doxycycline Mono 100 mg capsules in unit dose packs of 50 units, with a contract ceiling value of $1,055.60. This delivery order, classified as a firm fixed price contract with no set-aside designation, represents a competitive award for pharmaceutical supplies to support federal medical procurement needs. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters and primary distribution operations. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. The parent contract enables AmerisourceBergen to supply a broad range of pharmaceutical products and medical supplies to military healthcare programs worldwide, including antibiotics such as doxycycline, supporting the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. As a major pharmaceutical distributor and critical vendor for federal medical procurement, AmerisourceBergen has demonstrated capability to fulfill competitive federal requirements through open competition across multiple therapeutic domains and contract values.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 8/6/25 |